More Pathkey.AI Limited news
Pathkey.AI LimitedASX: PKY

Cancer Trials Australia becomes MediaConsent collaborator

Jan 8, 2019 at 10:55 PM EST · Issued by Pathkey.AI Limited

Filed with ASX · Jan 8, 2019 at 10:55 PM EST · 3 pages · English

On 6ix: 6ix.com/news/cancer-trials-australia-becomes-mediaconsent-collaborator

Pathkey.AI Limited on 6ix

Story so far

  • Collaboration announced with Neuroscience Trials AustraliaNov 1, 2018
  • MediaConsent collaboration with St Vincents HospitalOct 22, 2018
  • MediaConsent launch Pilot program with Social Media EnergyOct 18, 2018

Earlier from Pathkey.AI

  • Capital Raise and Strategic Acquisition of LudomadeNov 15, 2018
  • Collaboration announced with Neuroscience Trials AustraliaOct 31, 2018
  • SRO partners with Secure One Button Login experts SAAVHAOct 25, 2018
  • Quarterly Report & Appendix 4COct 23, 2018
  • MediaConsent collaboration with St Vincents HospitalOct 21, 2018

Later from Pathkey.AI

  • Appendix 4C - monthlyJan 30, 2019
  • Pause in TradeJan 31, 2019
  • Changes to Board of DirectorsFeb 1, 2019
  • Reinstatement to Trading on the ASXFeb 6, 2019
  • Half Year Financial Report & Appendix 4DFeb 28, 2019
All Pathkey.AI news releases↗

Follow Pathkey.AI into a list and get an email when it puts out news.

Follow Pathkey.AI
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer